Terms: = Skin cancer AND HLA-A, P01892, 3105, ENSG00000206503, P16188, P30447, P13746, P04439 AND Diagnosis
14 results:
1. Practical guidelines for the management of adverse events of the T cell engager bispecific tebentafusp.
Hassel JC; Berking C; Forschner A; Gebhardt C; Heinzerling L; Meier F; Ochsenreither S; Siveke J; Hauschild A; Schadendorf D
Eur J Cancer; 2023 Sep; 191():112986. PubMed ID: 37595494
[TBL] [Abstract] [Full Text] [Related]
2. Allopurinol hepatotoxicity is associated with human leukocyte antigen Class I alleles.
Fontana RJ; Li YJ; Phillips E; Saeed N; Barnhart H; Kleiner D; Hoofnagle J;
Liver Int; 2021 Aug; 41(8):1884-1893. PubMed ID: 33899326
[TBL] [Abstract] [Full Text] [Related]
3. Association of HLA Antigen Mismatch With Risk of Developing skin cancer After Solid-Organ Transplant.
Gao Y; Twigg AR; Hirose R; Roll GR; Nowacki AS; Maytin EV; Vidimos AT; Rajalingam R; Arron ST
JAMA Dermatol; 2019 Mar; 155(3):307-314. PubMed ID: 30673077
[TBL] [Abstract] [Full Text] [Related]
4. Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia.
Maslak PG; Dao T; Bernal Y; Chanel SM; Zhang R; Frattini M; Rosenblat T; Jurcic JG; Brentjens RJ; Arcila ME; Rampal R; Park JH; Douer D; Katz L; Sarlis N; Tallman MS; Scheinberg DA
Blood Adv; 2018 Feb; 2(3):224-234. PubMed ID: 29386195
[TBL] [Abstract] [Full Text] [Related]
5. Efficacy and safety of garenoxacin tablets on clinically diagnosed atypical pneumonia: postmarketing surveillance in Japan.
Izumikawa K; Watanabe A; Miyashita N; Ishida T; Hosono H; Kushimoto S; Kohno S
J Infect Chemother; 2014 Sep; 20(9):541-8. PubMed ID: 24934886
[TBL] [Abstract] [Full Text] [Related]
6. [cancer mortality in Southern Italy, 1999-2003].
Bidoli E; Montella M; Bruzzone S; De Paoli A; Fusco M; Frova L; Pace M; Pappagallo M; Serraino D
Epidemiol Prev; 2011; 35(3-4):200-6. PubMed ID: 21914916
[TBL] [Abstract] [Full Text] [Related]
7. The common Scandinavian human leucocyte antigen ancestral haplotype 62.1 as prognostic factor in patients with advanced malignant melanoma.
Helgadottir H; Andersson E; Villabona L; Kanter L; van der Zanden H; Haasnoot GW; Seliger B; Bergfeldt K; Hansson J; Ragnarsson-Olding B; Kiessling R; Masucci GV
Cancer Immunol Immunother; 2009 Oct; 58(10):1599-608. PubMed ID: 19214504
[TBL] [Abstract] [Full Text] [Related]
8. Immunogenetic heterogeneity in single-system and multisystem langerhans cell histiocytosis.
Bernstrand C; Carstensen H; Jakobsen B; Svejgaard A; Henter JI; Olerup O
Pediatr Res; 2003 Jul; 54(1):30-6. PubMed ID: 12700369
[TBL] [Abstract] [Full Text] [Related]
9. Distant metastases in ovarian carcinoma.
Cormio G; Rossi C; Cazzolla A; Resta L; Loverro G; Greco P; Selvaggi L
Int J Gynecol Cancer; 2003; 13(2):125-9. PubMed ID: 12657111
[TBL] [Abstract] [Full Text] [Related]
10. Heterogeneous expression of melanoma-associated antigens and hla-a2 in metastatic melanoma in vivo.
Cormier JN; Hijazi YM; Abati A; Fetsch P; Bettinotti M; Steinberg SM; Rosenberg SA; Marincola FM
Int J Cancer; 1998 Feb; 75(4):517-24. PubMed ID: 9466650
[TBL] [Abstract] [Full Text] [Related]
11. Immunophenotypically varied cell subpopulations in primary and metastatic human melanomas. Monoclonal antibodies for diagnosis, detection of neoplastic progression and receptor directed immunotherapy.
Bodey B; Kaiser HE; Goldfarb RH
Anticancer Res; 1996; 16(1):517-31. PubMed ID: 8615665
[TBL] [Abstract] [Full Text] [Related]
12. The value of blood group-specific lectin and endothelial associated antibodies in the diagnosis of vascular proliferations.
Suzuki Y; Hashimoto K; Crissman J; Kanzaki T; Nishiyama S
J Cutan Pathol; 1986 Dec; 13(6):408-19. PubMed ID: 3102581
[TBL] [Abstract] [Full Text] [Related]
13. Phenotyping of lesions of melanocyte origin with monoclonal antibodies to melanoma-associated antigens and to HLA antigens.
Natali PG; Bigotti A; Cavaliere R; Nicotra MR; Ferrone S
J Natl Cancer Inst; 1984 Jul; 73(1):13-24. PubMed ID: 6376904
[TBL] [Abstract] [Full Text] [Related]
14. Immunologic evaluation in the prognosis of acute lymphoblastic leukemia. A report from Childrens cancer Study Group.
Leikin S; Miller D; Sather H; Albo V; Esber E; Johnson A; Rogentine N; Hammond D
Blood; 1981 Sep; 58(3):501-8. PubMed ID: 6942846
[TBL] [Abstract] [Full Text] [Related]
